Aside from spending thousands on mileage reimbursement, large pharmaceutical employers are among the few to still offer company cars. As if margin pressure wasn’t enough, new regulatory and competitive challenges are adding more stress to pharmaceutical business leaders’ workloads. Patent cliffs continue to threaten pharma revenue, amounting to a more than $14 billion reduction in…